What is Aflac's medical and other health — issuances?

Aflac (AFL) reported medical and other health — issuances of $154M in Q2 2026.

How has Aflac's medical and other health — issuances changed year-over-year?

Aflac's medical and other health — issuances increased by 116.9% year-over-year, from $71M to $154M.

What is the long-term trend for Aflac's medical and other health — issuances?

Over 4 years (2021 to 2025), Aflac's medical and other health — issuances has grown at a -31.1% compound annual growth rate (CAGR), from $1.16B to $260M.

What does medical and other health — issuances mean?

The value of new insurance policies issued during the period that contribute to the liability for future policy benefits. This represents the volume of new business added to the medical and health segment.

Aflac (AFL) Medical and other health — Issuances

Screener

Other product segments

Life insurance

$166M+13.7%

Other

$122M+62.7%

Critical care

$85M-11.5%

Disability

$71M-10.1%

Accident

$58M-3.3%

Hospital indemnity

$41M+2.5%

Dental/vision

$10M-28.6%

Similar metrics at other companies

EQHHealth — Issuances

$0—

HMNSupplemental health — Issuances

$5.4M-11.5%

CNOSupplemental health — Issuances

$68.4M+7.9%

GLHealth — Issuances

$328.51M+55.2%

METAccident & health insurance — Issuances

$184M-38.3%

CNOMedicare supplement — Issuances

$144.3M+50.0%

Other financials

Income statement

See full

Revenue$4.1B-1.0%

Net income$825.0M+37.7%

EPS (diluted)$1.63+46.8%

Balance sheet

See full

Cash & equivalents$6.1B-12.1%

Total debt$8.8B-2.4%

Total equity$30.3B+11.4%

Total assets$115.96B-7.0%

Cash flow

See full

Operating cash flow$112.0M-71.9%

Valuation

See full

Market cap$63.91B+16.8%

Enterprise value$66.6B+17.3%

P/E13.1×-9.3×

P/S3.5×+0.1×

Profitability

See full

Net margin26.9%+11.6pp

Returns & leverage

See full

Return on equity16.9%+7.8pp

Debt / equity0.3×0.0×

Where this comes from

Reported directly by Aflac in its filing.

Tagged under the XBRL concept us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance.

The source filing: Aflac’s 10-Q, filed August 7, 2026.

Filed: Aug 7, 2026, 9:18 AM EDT
Fiscal quarter: Q2 FY2026
Calendar quarter: Q2 2026
Accession: 0001628280-26-054618

(In millions)	Aflac Japan / Cancer	Aflac Japan / Medicaland Other Health	Aflac Japan / Life Insurance	Aflac Japan / Other	Aflac U.S. / Accident	Aflac U.S. / Disability	Aflac U.S. / Critical Care	Aflac U.S. / Hospital Indemnity	Aflac U.S. / Dental/Vision	Aflac U.S. / Life Insurance	Aflac U.S. / Other
Effect of changes in cash flow assumptions	0	0	0	0	0	0	0	0	0	0	0
Effect of actual variances from expected experience	(277)	(187)	(46)	(13)	(40)	9	(46)	(12)	(4)	(39)	(48)
Adjusted beginning of period balance	36,161	21,792	25,670	4,745	3,308	2,410	11,766	2,059	454	2,249	2,256
Issuances	428	169	169	3	174	186	300	136	24	182	595
Interest accrual	602	265	265	43	69	50	256	44	10	48	73
Benefit payments	(1,264)	(485)	(1,080)	(108)	(251)	(238)	(489)	(159)	(30)	(57)	(133)
Foreign currency translation	(1,293)	(782)	(903)	(168)	0	0	0	0	0	0	0
Other	0	0	0	0	0	0	0	0	0	0	0

Item 1. Financial Statements (Unaudited)

FAQ

What is Aflac's medical and other health — issuances?: Aflac (AFL) reported medical and other health — issuances of $154M in Q2 2026.
How has Aflac's medical and other health — issuances changed year-over-year?: Aflac's medical and other health — issuances increased by 116.9% year-over-year, from $71M to $154M.
What is the long-term trend for Aflac's medical and other health — issuances?: Over 4 years (2021 to 2025), Aflac's medical and other health — issuances has grown at a -31.1% compound annual growth rate (CAGR), from $1.16B to $260M.
What does medical and other health — issuances mean?: The value of new insurance policies issued during the period that contribute to the liability for future policy benefits. This represents the volume of new business added to the medical and health segment.